The lymphocytes from eight patients with active visceral leishmaniasis (VL), a disease associated with marked immunologic dysfunction, were examined for ability to produce interleukin 2 (IL-2) and gamma interferon during in vitro cultivation. It was found that both IL-2 and gamma interferon production, in response to leishmania antigen, was absent during the active disease, but was restored after successful chemotherapy. Untreated VL patients produced IL-2 and gamma interferon when stimulated with phytohemagglutinin (PHA). Six patients with either active cutaneous or mucosal leishmaniasis, a disease not associated with immunosuppression, showed high levels of gamma interferon in response to leishmania antigen and PHA. Since IL-2 and gamma interferon have been shown to have important roles in the immune response and in the killing of leishmania, their absence may represent a key defect in the immune response in VL.
E M Carvalho, R Badaró, S G Reed, T C Jones, W D Johnson Jr
Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1973 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 2 | 2 | 1 | 1 | 3 | 2 | 1 | 5 | 3 | 8 | 4 | 7 | 7 | 6 | 12 | 7 | 6 | 5 | 9 | 9 | 10 | 6 | 6 | 5 | 5 | 9 | 12 | 5 | 3 | 5 | 11 | 19 | 11 | 10 | 7 | 7 | 8 | 8 | 3 | 2 | 1 | 253 |
Title and authors | Publication | Year |
---|---|---|
Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime®) and the recombinant Leish-110f®+MPL-SE® vaccine to treat canine visceral leishmaniasis
J Miret, E Nascimento, W Sampaio, JC França, RT Fujiwara, A Vale, ES Dias, E Vieira, RT da Costa, W Mayrink, AC Neto, S Reed |
Vaccine | 2008 |
Immuno stimulating glycophosphosphingolipid antigen from Leishmania donovani is recognized by visceral leishmaniasis patient sera
SK Bhaumik, MK Singh, S Karmakar, T De |
Molecular and Biochemical Parasitology | 2008 |
Kinesin Motor Domain of Leishmania donovani as a Future Vaccine Candidate
A Dey, P Sharma, NS Redhu, S Singh |
Clinical and vaccine immunology : CVI | 2008 |
Immunological and Genetic Evidence for a Crucial Role of IL-10 in Cutaneous Lesions in Humans Infected with Leishmania braziliensis
A Salhi, V Rodrigues, F Santoro, H Dessein, A Romano, LR Castellano, M Sertorio, S Rafati, C Chevillard, A Prata, A Alcaïs, L Argiro, A Dessein |
Journal of immunology (Baltimore, Md. : 1950) | 2008 |
A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs
RC Giunchetti, R Corrêa-Oliveira, OA Martins-Filho, A Teixeira-Carvalho, BM Roatt, RD de Oliveira Aguiar-Soares, W Coura-Vital, RT de Abreu, LC Malaquias, NF Gontijo, C Brodskyn, CI de Oliveira, DJ Costa, M de Lana, AB Reis |
Vaccine | 2008 |